1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Belgium Pharmaceuticals and Healthcare Report Q3 2016

Belgium Pharmaceuticals and Healthcare Report Q3 2016

  • May 2016
  • -
  • Business Monitor International
  • -
  • 82 pages

Includes 3 FREE quarterly updates

BMI View: Belgium offers a stable pharmaceutical market with high per capita spending on medicines.However, drugmakers will increasingly find the government less willing to reimburse expensive, innovativemedicines as it struggles to hit its fiscal targets.

Headline Expenditure Projections

- Pharmaceuticals: From EUR5.84bn (USD6.47bn) in 2015 to EUR5.89bn (USD6.30bn) in 2016; +0.9%in local currency terms and -2.6% in US dollar terms.

- Healthcare: From EUR44.96bn (USD49.87bn) in 2015 to EUR46.13bn (USD49.36bn) 2016; +2.6% inlocal currency terms and -1.0% in US dollar terms.

Table Of Contents

Belgium Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Belgium 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Belgium 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Belgium 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Belgium 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Belgium 2012-2020) 16
Prescription Drug Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Belgium 2012-2020) 18
Patented Drug Market Forecast 19
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Belgium 2012-2020) 21
Generc Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Belgium 2012-2020) 24
OTC Medicine Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Belgium 2012-2020) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Belgium 2014-2020) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Belgium 2014-2020) 29
Industry Risk/Reward Index 30
Western Europe Risk/Reward Index 30
Belgium Risk/Reward Index 35
Rewards 35
Risks 35
Regulatory Review 37
Intellectual Property Issues 39
Pricing Regime 39
Reimbursement Regime 41
Table: Reimbursements by Category, 2009 43
Table: Price Build-Up for OTC Medicines 45
Market Overview 46
Healthcare Sector 46
Table: Healthcare Resources (Belgium 2010-2015) 48
Table: Healthcare Personnel (Belgium 2010-2015) 48
Table: Healthcare Activity (Belgium 2010-2015) 49
Research and Development 50
Clinical Trials 51
Epidemiology 52
Competitive Landscape 55
Research-Based Industry 55
Table: Multinational Market Activity 56
Pharmaceutical Distribution 58
Pharmaceutical Retail Sector 58
Company Profile 60
Galapagos 60
Janssen Pharmaceutica 64
UCB Pharma 67
Demographic Forecast 71
Table: Population Headline Indicators (Belgium 1990-2025) 72
Table: Key Population Ratios (Belgium 1990-2025) 72
Table: Urban/Rural Population and Life Expectancy (Belgium 1990-2025) 73
Table: Population By Age Group (Belgium 1990-2025) 73
Table: Population By Age Group % (Belgium 1990-2025) 74
Glossary 76
Methodology 78
Pharmaceutical Expenditure Forecast Model 78
Healthcare Expenditure Forecast Model 78
Notes On Methodology 79
Risk/Reward Index Methodology 80
Index Overview 81
Table: Pharmaceutical Risk/Reward Index Indicators 81
Indicator Weightings 82

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.